{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:51:03Z","timestamp":1791773463054,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["K12 TR004930"],"award-info":[{"award-number":["K12 TR004930"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03A259489"],"award-info":[{"award-number":["R03A259489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA251654"],"award-info":[{"award-number":["K08CA251654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtct.2025.06.030","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:16:11Z","timestamp":1751429771000},"page":"774-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3781-5441","authenticated-orcid":false,"given":"Rahul","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermioni L.","family":"Amonoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-5920","authenticated-orcid":false,"given":"Anna","family":"Barata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel S.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel R.","family":"Espinoza-Gutarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-5945","authenticated-orcid":false,"given":"Reena V.","family":"Jayani-Kosarzycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9661-7410","authenticated-orcid":false,"given":"Hannah","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Nawas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8000-0179","authenticated-orcid":false,"given":"Angela","family":"Steineck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wanjiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Cusatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9140-3109","authenticated-orcid":false,"given":"Jennifer M.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-8239","authenticated-orcid":false,"given":"Helene","family":"Schoemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Sidana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-641X","authenticated-orcid":false,"given":"Anthony D.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-8955","authenticated-orcid":false,"given":"Catherine J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-6539","authenticated-orcid":false,"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cncr.29717","article-title":"Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)","volume":"122","author":"Wood","year":"2016","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0002","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/cncr.35189","article-title":"Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients","volume":"130","author":"Shaw","year":"2024","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.jtct.2025.06.030_bib0003","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1002\/cncr.30936","article-title":"Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful","volume":"123","author":"Shaw","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.26768","article-title":"Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102","volume":"98","author":"Cusatis","year":"2023","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.030_bib0005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0006","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","article-title":"International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL consortium","volume":"21","author":"Coens","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0007","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41409-022-01733-3","article-title":"Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network","volume":"57","author":"Perovic","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.030_bib0008","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41409-023-02087-0","article-title":"Psychosocial assessment practices for hematopoietic stem cell transplantation: a national survey study","volume":"58","author":"Wiener","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0009","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/bmt.2016.113","article-title":"Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN","volume":"51","author":"Shaw","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0010","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.bbmt.2020.01.022","article-title":"Systematic review of patient-reported outcome measures in graft-versus-host disease","volume":"26","author":"Kilgour","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0011","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1016\/S1470-2045(24)00256-0","article-title":"Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignancies","volume":"25","author":"Khatsuria","year":"2024","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0012","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.bbmt.2018.11.025","article-title":"Patient-reported outcomes with chimeric antigen receptor T cell therapy: challenges and opportunities","volume":"25","author":"Chakraborty","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0013","article-title":"Patient-reported outcomes of chimeric antigen receptor T-cell therapy in hematologic malignancies: a systematic review and meta-analysis","volume":"14","author":"Park","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0014","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/cncr.30546","article-title":"Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation","volume":"123","author":"El-Jawahri","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2015-08-662874","article-title":"Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease","volume":"127","author":"Palmer","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0016","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.bbmt.2018.07.020","article-title":"Impact of psychological distress on quality of life, functional status, and survival in patients with chronic graft-versus-host disease","volume":"24","author":"El-Jawahri","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","article-title":"Quality of life after allogeneic hematopoietic cell transplantation","volume":"114","author":"Pidala","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.jtct.2025.06.030_bib0018","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.2022015478","article-title":"Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma","volume":"140","author":"Elsawy","year":"2022","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jtct.2025.06.030_bib0019","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1182\/bloodadvances.2022008106","article-title":"Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL","volume":"6","author":"Abramson","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0020","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S2352-3026(24)00005-X","volume":"11","author":"Delforge","year":"2024","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0021","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3026(24)00320-X","article-title":"Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial","volume":"12","author":"Mina","year":"2025","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0022","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/bmt.2015.122","article-title":"Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients","volume":"50","author":"Hamilton","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0023","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbmt.2019.01.028","article-title":"Limitation in patient-reported function is associated with inferior survival in older adults undergoing autologous hematopoietic cell transplantation","volume":"25","author":"Nawas","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.030_bib0024","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbmt.2016.08.016","article-title":"Patient-reported outcomes and socioeconomic status as predictors of clinical outcomes after hematopoietic stem cell transplantation: a study from the blood and marrow transplant clinical trials network 0902 trial","volume":"22","author":"Knight","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/13696998.2020.1808981","article-title":"Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the treatment of relapsed\/refractory diffuse large B-cell lymphoma from Singapore's healthcare system perspective","volume":"23","author":"Cher","year":"2020","journal-title":"J Med Econ"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0026","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1182\/bloodadvances.2023011793","article-title":"Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma","volume":"8","author":"Choe","year":"2024","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0027","doi-asserted-by":"crossref","first-page":"917.e1","DOI":"10.1016\/j.jtct.2024.06.021","article-title":"Current trends and outcomes in cellular therapy activity in the United States, including prospective patient-reported outcomes data collection in the center for international blood and marrow transplant research registry","volume":"30","author":"Cusatis","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0028","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s11136-015-0992-9","article-title":"Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients","volume":"24","author":"Jensen","year":"2015","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0029","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jclinepi.2010.11.018","article-title":"Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients","volume":"64","author":"Yost","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.030_bib0030","first-page":"1723","article-title":"Utility of the patient-reported outcomes measurement information system (PROMIS) to measure primary health outcomes in cancer patients: a systematic review","volume":"29","author":"Tran","year":"2021","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0031","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11136-022-03324-7","article-title":"PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of health","volume":"32","author":"Hartmann","year":"2023","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0032","article-title":"Evaluating the psychometric properties of the simplified Chinese version of PROMIS-29 version 2.1 in patients with hematologic malignancies","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4143\/crt.2020.1200","article-title":"Validation of the Korean version of the patient-reported outcomes measurement information system 29 profile V2.1 among cancer survivors","volume":"54","author":"Kang","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27353","article-title":"Translation, psychometric validation, and baseline results of the patient-reported outcomes measurement information system (PROMIS) pediatric measures to assess health-related quality of life of patients with pediatric lymphoma in malawi","volume":"65","author":"Westmoreland","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2025.06.030_bib0035","first-page":"2289","article-title":"Visualizing the patient-reported outcomes measurement information system (PROMIS) measures for clinicians and patients","volume":"2017","author":"Grossman","year":"2018","journal-title":"AMIA Annu Symp Proc"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0036","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/j.eats.2019.01.012","article-title":"Using a web-based data collection platform to implement an effective electronic patient-reported outcome registry","volume":"8","author":"Lizzio","year":"2019","journal-title":"Arthrosc Tech"},{"issue":"suppl 2","key":"10.1016\/j.jtct.2025.06.030_bib0037","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1016\/j.jtct.2023.12.486","article-title":"Standard of care electronic patient reported outcomes using promis-29 after hematopoietic stem cell ttransplant and chimeric antigen receptor T cell therapy","volume":"30","author":"Korsos","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0038","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0272989X18776637","article-title":"Estimation of a preference-based summary score for the patient-reported outcomes measurement information system: the PROMIS(R)-preference (PROPr) scoring system","volume":"38","author":"Dewitt","year":"2018","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jtct.2025.06.030_bib0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2022.09.010","article-title":"Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS preference score","volume":"152","author":"Klapproth","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jtct.2021.06.007","article-title":"Biobehavioral research and hematopoietic stem cell transplantation: expert review from the biobehavioral research special interest group of the American Society for Transplantation and Cellular Therapy","volume":"27","author":"Kelly","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0041","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/01466216211013106","article-title":"PROsetta: an R package for linking patient-reported outcome measures","volume":"45","author":"Choi","year":"2021","journal-title":"Appl Psychol Meas"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.030_bib0042","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cncr.31089","article-title":"PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors","volume":"124","author":"Shaw","year":"2018","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0043","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/cam4.3664","article-title":"Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel","volume":"10","author":"Hoogland","year":"2021","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.030_bib0044","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.jtct.2022.05.015","article-title":"Change in patients' perceived cognition following chimeric antigen receptor T-cell therapy for lymphoma","volume":"28","author":"Barata","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.030_bib0045","doi-asserted-by":"crossref","first-page":"452.e1","DOI":"10.1016\/j.jtct.2024.01.063","article-title":"Quality of life and prognostic awareness in caregivers of patients receiving chimeric antigen receptor T cell therapy","volume":"30","author":"Barata","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0046","doi-asserted-by":"crossref","first-page":"111853","DOI":"10.1016\/j.jclinepi.2025.111853","article-title":"Development and validation of crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status\/quality of life scales and their corresponding PROMIS scales","volume":"184","author":"Oerlemans","year":"2025","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0047","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cncr.30354","article-title":"Responsiveness of 8 patient-reported outcomes measurement information system (PROMIS) measures in a large, community-based cancer study cohort","volume":"123","author":"Jensen","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0048","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1200\/OP.23.00356","article-title":"Thresholds in PROMIS scores anchored to subsequent unscheduled health service use among people diagnosed with cancer","volume":"20","author":"Sikorskii","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0049","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s11136-021-02925-y","article-title":"Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures","volume":"30","author":"Terwee","year":"2021","journal-title":"Qual Life Res"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0050","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3324\/haematol.2018.192930","article-title":"Patient-reported outcomes and health status associated with chronic graft-versus-host disease","volume":"103","author":"Lee","year":"2018","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.030_bib0051","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/pon.5674","article-title":"Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy","volume":"30","author":"Barata","year":"2021","journal-title":"Psychooncology"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.030_bib0052","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41409-023-02091-4","article-title":"Randomized phase 2 study of digital life coaching during transplantation for myeloma","volume":"58","author":"Banerjee","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0053","doi-asserted-by":"crossref","DOI":"10.2196\/33701","article-title":"Digital life coaching during stem cell transplantation: development and usability study","volume":"6","author":"Banerjee","year":"2022","journal-title":"JMIR Form Res"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.030_bib0054","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0056","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2025.06.030_bib0057","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1182\/blood-2024-203741","article-title":"Health related quality of life (HRQoL) in relapsed\/refractory multiple myeloma (RRMM): a systematic literature review (SLR) and meta-analysis","volume":"144","author":"Banerjee","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0058","doi-asserted-by":"crossref","first-page":"157.e1","DOI":"10.1016\/j.jtct.2024.12.020","article-title":"Real-world patient-reported and neurocognitive outcomes in the year after axicabtagene ciloleucel","volume":"31","author":"Hoogland","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0059","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbmt.2012.11.014","article-title":"Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation","volume":"19","author":"Wood","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0060","first-page":"1223","article-title":"Pilot randomized trial of an electronic symptom monitoring and reporting intervention for hospitalized adults undergoing hematopoietic stem cell transplantation","volume":"28","author":"Bryant","year":"2019","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0061","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-024-02909-8","article-title":"A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide","volume":"30","author":"Crossnohere","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0062","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpainsymman.2011.08.011","article-title":"Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation","volume":"44","author":"Cohen","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0063","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-13-2442","article-title":"Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2025.06.030_bib0064","article-title":"eSyM: an electronic health record-integrated patient-reported outcomes-based cancer symptom management program used by six diverse health systems","volume":"6","author":"Hassett","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clml.2024.07.018","article-title":"SOHO state of the art updates and next questions | measuring patient-reported outcomes (PROs) and treatment tolerability in patients with hematologic malignancies","volume":"25","author":"Major","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0066","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s41687-020-00271-0","volume":"4","author":"Lee","year":"2020","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0067","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpainsymman.2021.07.031","article-title":"Evaluating treatment tolerability using the toxicity index with patient-reported outcomes data","volume":"63","author":"Langlais","year":"2022","journal-title":"J Pain Symptom Manage"},{"issue":"34","key":"10.1016\/j.jtct.2025.06.030_bib0068","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.21.00910","article-title":"Toxicity index, patient-reported outcomes, and early discontinuation of endocrine therapy for breast cancer risk reduction in NRG oncology\/NSABP B-35","volume":"39","author":"Henry","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0069","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S2352-3026(22)00045-X","article-title":"Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies","volume":"9","author":"Thanarajasingam","year":"2022","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(16)00038-3","article-title":"Longitudinal adverse event assessment in oncology clinical trials: the toxicity over time (ToxT) analysis of alliance trials NCCTG N9741 and 979254","volume":"17","author":"Thanarajasingam","year":"2016","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0071","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.3390\/cancers14112742","article-title":"Longitudinal collection of patient-reported outcomes and activity data during CAR-T therapy: feasibility, acceptability, and data visualization","volume":"14","author":"Oswald","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.030_bib0072","doi-asserted-by":"crossref","first-page":"1219.e1","DOI":"10.1016\/j.jtct.2024.09.013","article-title":"Prospective assessment of quality of life and patient-reported toxicities over the first year after chimeric antigen receptor T-cell therapy","volume":"30","author":"Hoogland","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"19","key":"10.1016\/j.jtct.2025.06.030_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194711","article-title":"Patient-reported outcomes among multiple mmyeloma patients treated with standard of care idecabtagene vicleucel","volume":"15","author":"Oswald","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.030_bib0074","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jtct.2022.05.004","article-title":"Longitudinal patient reported outcomes with CAR-T cell therapy versus autologous and allogeneic stem cell transplant","volume":"28","author":"Sidana","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.06.030_bib0075","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/CCI.20.00081","article-title":"Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial","volume":"4","author":"Basch","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.030_bib0076","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.030_bib0077","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s11136-020-02448-y","article-title":"FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease","volume":"29","author":"King-Kallimanis","year":"2020","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0078","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11899-019-0494-x","article-title":"Graft versus host disease clinical trials: is it time for patients centered outcomes to be the primary objective?","volume":"14","author":"Shaw","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0079","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41409-024-02374-4","article-title":"Standardized translations of the Lee Chronic GvHD symptom scale to 12 European languages: an EU COST action cGvHD eurograft project","volume":"59","author":"Gjaerde","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0080","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.jtct.2023.03.016","article-title":"Feasibility of a new model of care for allogeneic stem cell transplantation recipients facilitated by eHealth: the MY-medula pilot study","volume":"29","author":"Redondo","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.06.030_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2020.101723","article-title":"Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: a mixed-methods contextual analysis as part of the SMILe study","volume":"45","author":"Leppla","year":"2020","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0082","article-title":"Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.jtct.2025.06.030_bib0083","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1182\/bloodadvances.2020002204","article-title":"The transplant evaluation rating scale predicts overall survival after allogeneic hematopoietic stem cell transplantation","volume":"4","author":"Solh","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.030_bib0084","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/cncr.29818","article-title":"Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation","volume":"122","author":"El-Jawahri","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.030_bib0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.psym.2019.02.004","article-title":"Psychological considerations in hematopoietic stem cell transplantation","volume":"60","author":"Amonoo","year":"2019","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0086","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jha2.148","article-title":"Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantation","volume":"2","author":"Banerjee","year":"2021","journal-title":"EJHaem"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0087","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/bloodadvances.2023011081","article-title":"Coping in patients with hematologic malignancies undergoing hematopoietic cell transplantation","volume":"8","author":"Newcomb","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0088","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/cncr.34557","article-title":"Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy","volume":"129","author":"Dhawale","year":"2023","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0089","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1083-8791(03)00103-4","article-title":"Optimistic expectations and survival after hematopoietic stem cell transplantation","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbmt.2019.09.037","article-title":"Patient-reported neuropsychiatric outcomes of long-term survivors after chimeric antigen receptor T cell therapy","volume":"26","author":"Ruark","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.030_bib0091","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/abm\/kaaa091","article-title":"Management of distress in patients with cancer-are we doing the right tthing?","volume":"54","author":"Dekker","year":"2020","journal-title":"Ann Behav Med"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0092","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/tbm\/iby123","article-title":"Screening for psychosocial distress among patients with cancer: implications for clinical practice, healthcare policy, and dissemination to enhance cancer survivorship","volume":"9","author":"Ehlers","year":"2019","journal-title":"Transl Behav Med"},{"issue":"2 D","key":"10.1016\/j.jtct.2025.06.030_bib0093","article-title":"A positive psychology intervention in allogeneic hematopoietic stem cell transplantation survivors (PATH): a pilot randomized clinical trial","volume":"22","author":"Amonoo","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.030_bib0094","doi-asserted-by":"crossref","first-page":"1217.e1","DOI":"10.1016\/j.jtct.2024.09.022","article-title":"A peer support intervention in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): the STEPP proof-of-concept trial","volume":"30","author":"Amonoo","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0095","article-title":"How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 generic core scales","volume":"5","author":"Varni","year":"2007","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0096","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12874-023-02096-z","article-title":"Methods, strategies, and incentives to increase response to mental health surveys among adolescents: a systematic review","volume":"23","author":"Bidonde","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0097","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064285","article-title":"Accelerating innovation in primary care to support adolescent health discussions","volume":"154","author":"Jenssen","year":"2024","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.030_bib0098","doi-asserted-by":"crossref","first-page":"679.e1","DOI":"10.1016\/j.jtct.2021.04.013","article-title":"Return to work among young adult survivors of allogeneic hematopoietic cell transplantation in the United States","volume":"27","author":"Bhatt","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"10 Suppl","key":"10.1016\/j.jtct.2025.06.030_bib0099","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/cncr.26056","article-title":"Psychological, social, and behavioral issues for young adults with cancer","volume":"117","author":"Zebrack","year":"2011","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.jtct.2025.06.030_bib0100","article-title":"Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study","volume":"8","author":"Mitchell","year":"2024","journal-title":"Front Psych"},{"issue":"16","key":"10.1016\/j.jtct.2025.06.030_bib0101","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/cncr.33617","article-title":"Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy","volume":"127","author":"Leahy","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtct.2023.10.005","article-title":"INSPIRED symposium part 4A: access to CAR T cell therapy in unique populations with B cell acute lymphoblastic leukemia","volume":"30","author":"Winestone","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0103","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jpepsy\/jsj078","article-title":"Maternal perspectives on children's health-related quality of life during the first year after pediatric hematopoietic stem cell transplant","volume":"31","author":"Parsons","year":"2006","journal-title":"J Pediatr Psychol"},{"issue":"22","key":"10.1016\/j.jtct.2025.06.030_bib0104","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1002\/cncr.29597","article-title":"Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings","volume":"121","author":"Zhukovsky","year":"2015","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.2861","article-title":"Agreement between child self-report and caregiver-proxy report for symptoms and functioning of children undergoing cancer treatment","volume":"174","author":"Mack","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0106","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.2868","article-title":"Patient-reported outcomes in pediatric oncology","volume":"174","author":"Leahy","year":"2020","journal-title":"JAMA Pediatrics"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.030_bib0107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/hematology.2024000536","article-title":"Patient-reported outcomes after CAR T-cell therapy in patients with hematological malignancies","volume":"2024","author":"Wang","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.030_bib0108","first-page":"462.e1","article-title":"Parent psychological distress is associated with symptom burden and health-related quality of life in children and adolescents undergoing stem","volume":"29","author":"Ward","year":"2023","journal-title":"Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.030_bib0109","first-page":"209","article-title":"Relationships between parental anxiety and child quality of life in advanced childhood cancer","volume":"40","author":"Cowfer","year":"2023","journal-title":"J Pediatr Hematol Oncol Nurs"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.030_bib0110","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/pbc.26112","article-title":"Predictors of health-related quality of life over time among pediatric hematopoietic stem cell transplant recipients","volume":"63","author":"Loiselle","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0111","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31092","article-title":"Weathering the storm when the end of the road is near: a qualitative analysis of supportive care needs during CAR T-cell therapy in pediatrics","volume":"71","author":"Steineck","year":"2024","journal-title":"Pediatric Blood & Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0112","first-page":"4747","article-title":"Understanding the financial and psychological impact of employment disruption among caregivers of pediatric HSCT recipients: a mixed methods analysis","volume":"30","author":"Biddell","year":"2022","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0113","first-page":"2","article-title":"Using the science of psychosocial care to implement the new American College of Surgeons Commission on cancer distress screening standard","volume":"2013","author":"Wagner","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.030_bib0114","article-title":"Systematic screening and assessment of psychosocial well-being and care needs of people with cancer","volume":"3","author":"Schouten","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0115","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbmt.2018.01.029","article-title":"Engaging patients in setting a patient-centered outcomes research agenda in hematopoietic cell transplantation","volume":"24","author":"Burns","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.030_bib0116","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bbmt.2019.02.017","article-title":"A conceptual framework and key research questions in educational needs of blood and marrow ttransplantation patients, caregivers, and families","volume":"25","author":"Schoemans","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.030_bib0117","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41409-024-02290-7","article-title":"Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party","volume":"59","author":"Schoemans","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0118","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.bbmt.2020.08.002","article-title":"Driving distance and patient-reported outcomes in hematopoietic cell transplantation survivors","volume":"26","author":"Banerjee","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.030_bib0119","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 health survey for use in Japan","volume":"15","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.030_bib0120","first-page":"1427","article-title":"The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners","volume":"30","author":"Cheung","year":"2022","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.030_bib0121","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41591-022-01781-8","article-title":"Patient reported outcome assessment must be inclusive and equitable","volume":"28","author":"Calvert","year":"2022","journal-title":"Nat Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:37:09Z","timestamp":1790825829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":121,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666636725012849"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.030","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}